Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance. [electronic resource]
Producer: 20151001Description: 504-16 p. digitalISSN:- 0946-1965
- Anticonvulsants -- adverse effects
- Area Under Curve
- Biotransformation
- Case-Control Studies
- Cytochrome P-450 CYP2C9 -- genetics
- Epilepsy -- drug therapy
- Gene Frequency
- Genotype
- Humans
- India
- Metabolic Clearance Rate
- Pharmacogenetics
- Pharmacovigilance
- Phenotype
- Phenytoin -- adverse effects
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Polymorphism, Restriction Fragment Length
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.